Serum level of semicarbazide-sensitive amine oxidase in children with ADHD

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages

  Roessner, Veit ^a   Uebel, Henrik ^a   Becker, Andreas ^a   Beck, Georg ^b   Bleich, Stefan ^b   Rothenberger, Aribert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); PSYCHOSTIMULANT AGENT; SEMICARBAZIDE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERKINESIA; INTERNATIONAL CLASSIFICATION OF DISEASES; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; VOLUNTEER;

EID: 33646425621     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-5     Document Type: Article

References (30)

1. Rothenberger A, Döpfner M, Sergeant S, Steinhausen HC: ADHD - beyond core symptoms. Eur Child Adolesc Psychiatry 2004, 13 Suppl 1:.
2. Shih JC, Thompson RF: Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 1999, 65:593-598.
3. Shekim WO, Bylund DB, Alexson J, Glaser RD, Jones SB, Hodges K, Perdue S: Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res 1986, 18:179-188.
4. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A: Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 2004, 13 Suppl 1:1102-16.
5. Himpel S, Banaschewski T, Heise CA, Rothenberger A: The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. Expert Opin Drug Saf 2005, 4:311-321.
6. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, Gill M, Hawi Z: Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941 G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 2005, 134:110-114.
7. Lawson DC, Turic D, Langley K, Pay HM, Govan CF, Norton N, Hamshere ML, Owen MJ, O'Donovan MC, Thapar A: Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2003, 116:84-89.
8. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP: Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002, 7:626-632.
9. Jiang S, Xin R, Lin S, Qian Y, Tang G, Wang D, Wu X: Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 2001, 105:783-788.
10. Tipton KF, Boyce S, O'Sullivan J, Davey GP, Healy J: Monoamine oxidases: certainties and uncertainties. Curr Med Chem 2004, 11:1965-1982.
11. Fitzgerald DH, Tipton KF: Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). J Neurol Transm 2002, 109:251-265.
12. Castillo V, Lizcano JM, Unzeta M: Presence of SSAO in human and bovine meninges and microvessels. Neurobiology (Bp) 1999, 7:263-272.
13. Castillo V, Lizcano JM, Visa J, Unzeta M: Semicarbazide-sensitive amine oxiclase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization. Neurochem Int 1998, 33:415-423.
14. Obata T. Semicarbazide-sensitive amine oxidase (SSAO) in the brain. Neurochem Res 2002, 27:263-268.
15. Döpfner M, Lehmkuhl G: Diagnostik-System für Psychische Störungen im Kindles- und Jugendalter nach ICD-10 und DSM-IV (DISYPS-KJ). 2nd edition. Bern, Huber; 2000.
16. Boomsma F, Hut H, Bagghoe U, van der Houwen A, van den Meiracker A: Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation. Med Sci Monit 2005, 11:RA 122-126.
17. Matyus P, Dajka-Halasz B, Foldi A, Haider N, Barlocco D, Magyar K: Semicarbazide-sensitive amine oxidase: current status and perspectives. Curr Med Chem 2004, 11:1285-1298.
18. Boomsma F, Bhaggoe UM, van der Houwen AM, van den Meiracker AH: Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta 2003, 1647:48-54.
19. van Dijk J, Boomsma F, Alberts G, Man in 't Veld AJ, Schalekamp MA: Determination of semicarbazide-sensitive amine oxidase activity in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Biomed Appl 1995, 663:43-50.
20. Pino R, Failli P, Mazzetti L, Buffoni F: Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in isolated cardiomyocytes of spontaneously hypertensive rats. Biochem Mol Med 1997, 62:188-196.
21. Guffroy C, Strolin Benedetti M: Monoamine oxidase and semicarbazide-sensitive amine oxidase in spontaneously hypertensive and in normotensive control rats. Life Sci 1984, 34:535-545.
22. Russell VA, Sagvolden T, Johansen EB: Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 2005, 1:9.
23. Roessner V, Weber A, Beck G, Frieling H, Bleich S: Decreased SSAO serum levels in patients with major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. submitted
24. Smeraldi C, Castillo V, Lizcano JM, Unzeta M: Some properties of semicarbazide-sensitive amine oxidase (SSAO) from human cerebrovascular tissues. Inflamm Res 2001, 50 Suppl 2:S144-5.
25. Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S: Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 2004, 95:50-57.
26. Hysmith RM, Boor PJ: In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells. J Cardiovasc Pharmacol 1987, 9:668-674.
27. Garcia-Vicente S, Abella A, Viguerie N, Ros-Baro A, Camps M, Testar X, Palacin M, Zorzano A, Marti L: The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha. J Physiol Biochem 2005, 61:395-401.
28. Ekblom J, Gronvall JL, Garpenstrand H, Nillson S, Oreland L: Is semicarbazide-sensitive amine oxidase in blood plasma partly derived from the skeleton? Neurobiology (Bp) 2000, 8:129-135.
29. Marcolin MA, Davis JM: Platelet monoamine oxidase in schizophrenia: a meta-analysis. Schizophr Res 1992, 7:249-267.
30. Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd ed edition. Hillsdale, NJ, Erlbaum; 1988.